Thomas J. Galloway

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

David G. Pfister, Sharon Spencer, David J. Adelstein et al. · Journal of the National Comprehensive Cancer Network · 2020 · 1.4K citations

Medicine, Oncology, Otolaryngology +17

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison, Andy Trotti, Jonathan Harris et al. · The Lancet · 2018 · 1.3K citations

Medicine, Oncology, Radiation Oncology +6

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022

Jimmy J. Caudell, Maura L. Gillison, Ellie Maghami et al. · Journal of the National Comprehensive Cancer Network · 2022 · 531 citations

Medicine, Oncology, Radiation Oncology +17

Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity

Phuc Félix Nguyen‐Tan, Qiang Zhang, K. Kian Ang et al. · Journal of Clinical Oncology · 2014 · 474 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States

Colin T. Murphy, Thomas J. Galloway, Elizabeth A. Handorf et al. · Journal of Clinical Oncology · 2015 · 428 citations

Public Health, Biostatistics, Oncology +15